בייאטה 5 מק"ג
Country: Israel
Language: Hebrew
Source: Ministry of Health
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
EXENATIDE 250 MCG/ML
Available from:
ASTRA ZENECA ISRAEL LTD
ATC code:
A10BX04
Pharmaceutical form:
SOLUTION FOR INJECTION
Administration route:
S.C
Manufactured by:
LILLY PHARMA FERT. & DISTRIB. GmbH & Co. KG
Therapeutic group:
EXENATIDE
Therapeutic indications:
Byetta is indicated as an adjunct to diet and exercise to improve glycimic control in adults with type 2 diabetes mellitus.Byetta is indicated as adjunctive therapy to improve glycemic control in patients with type 2 diabetes mellitus who are taking metformin or a sulfonylurea , alone or in combination, but have not achieved adequate glycemic control.
Authorization date:
2013-01-01
